{
    "code": 0,
    "data": [
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board meeting is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a62381a-70e7-4bcf-b5f8-8fdce9ce691f.pdf",
            "news_date": "2026-02-11 19:54:09"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Please find attached unaudited standalone and consolidated financial results for the year ended 31st December 2026",
            "news_id": "91f875c3-4b87-4b0c-8744-b63f597002d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=167c068f-1a60-47b0-8b17-eb30d9998667.pdf",
            "news_date": "2026-02-11 19:41:54",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Please find attached unaudited standalone and consolidated financial results for the year ended 31st December 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=167c068f-1a60-47b0-8b17-eb30d9998667.pdf",
            "news_date": "2026-02-11 19:41:54"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approval Unaudited Quarterly Financial Results For The Quarter Ended 31St December 2025 Bonus Issue Increase Authorised Capital Convene EGM Finalise Record Date",
            "news_body": "Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve unaudited quarterly financial results for the quarter ended 31st December 2025 Bonus Issue Increase Authorised Capital Convene EGM finalise record date",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=804df4d8-cef2-4c21-9f5b-50310c7731e0.pdf",
            "news_date": "2026-02-04 18:30:43"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We are submitting herewith the certificate under regulation74(5) received from our RTA",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86478d92-e444-4672-9934-386328970ad7.pdf",
            "news_date": "2026-01-15 11:50:11"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Trading window will be closed with effect from 1st January 2026 till expiry of 48 hours from the declaration of unaudited financial results of the company for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8d941dd-9992-47f0-908d-7854c11ceb77.pdf",
            "news_date": "2025-12-27 11:31:00"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We are hereby submitting the copy publication of extract of financial results for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73cb6dab-253a-48ee-aaf9-838ab096c713.pdf",
            "news_date": "2025-11-15 18:18:30"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Monitoring Agency Report",
            "news_body": "We are submitting herewith the report received from monitoring agency for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=150b113d-875e-42e1-9af4-54a7fd0b90fe.pdf",
            "news_date": "2025-11-14 20:51:09"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "We are submitting herewith the Press Release of Financial Results for H126",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2420b912-e394-48b3-b1df-7ea2923c6e18.pdf",
            "news_date": "2025-11-14 17:52:11"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "We are hereby submitting the Outcome Of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ce07c0f-3b99-4e3b-a551-cc84b0d97539.pdf",
            "news_date": "2025-11-13 19:00:18"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "We are hereby submitting the unaudited financial results for the quarter ended 30th September 2025",
            "news_id": "a6cfe1ee-659c-474f-9d58-d2bf7e47d6af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8560b609-928a-4099-8924-58d7fcadc3d1.pdf",
            "news_date": "2025-11-13 18:52:15",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "We are hereby submitting the unaudited financial results for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8560b609-928a-4099-8924-58d7fcadc3d1.pdf",
            "news_date": "2025-11-13 18:52:15"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Statement Of The Company For The Quarter Ended 30Th September 2025",
            "news_body": "Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Consideration and Approval of Unaudited Financial Statement of the Company for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2eb8178-683e-4ceb-9ea3-e8ced6d4e3ef.pdf",
            "news_date": "2025-11-08 14:43:07"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We are submitting herewith the certificate received from MUFG Intime India Private Limited for the quarter ended 30th September 2025 under Regulation 74(5) of SEBI (DP) Regulations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67706472-5fa0-4b5d-afd6-44a9498760b6.pdf",
            "news_date": "2025-10-14 14:39:34"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "We are submitting the scrutinizer report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78c600c7-1a9a-443a-a49c-95883cadf151.pdf",
            "news_date": "2025-09-27 12:39:52"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The trading window will be closed for all designated person of the Company with effect from 1st October 2025 and will remain close till 48 hours from the declaration of financial results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec97b410-0ff2-4f26-b551-a63080c804e7.pdf",
            "news_date": "2025-09-26 14:23:32"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "We are enclosing herewith the proceeding and outcome of 33rd Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c35b6945-da15-43e8-ab96-d7510e03d5f6.pdf",
            "news_date": "2025-09-26 14:08:08"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Letter To Shareholders - Annual Report For FY 2024-25",
            "news_body": "We are submitting herewith the letter dispatched to shareholders regarding the availability of annual report for fy 2024-25 in the website of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1209cbb8-ec70-4131-bcd8-faab1b018350.pdf",
            "news_date": "2025-09-05 20:39:11"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of Newspaper Publication of 33rd AGM notice of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66ca4fd2-c160-42d2-b044-f88ee9412c89.pdf",
            "news_date": "2025-09-03 23:05:27"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Book Closure",
            "caption": "Book Closure Intimation",
            "news_body": "Book Closure Intimation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=011e4387-03b2-4856-b5ed-1129d25a094c.pdf",
            "news_date": "2025-09-01 18:31:00"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of Annual General Meeting",
            "news_body": "We are hereby submitting herewith the notice of annual general meeting for your record",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cbd9a15-adef-4c38-b328-2c4ce930c3be.pdf",
            "news_date": "2025-09-01 16:57:11"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "We are hereby submitting the Annual Report for the FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34a970f7-b37d-40a2-b46e-a6fb69240f28.pdf",
            "news_date": "2025-09-01 16:11:02"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1339b45-18b7-4924-be9b-f1bcc7481579.pdf",
            "news_date": "2025-08-26 19:27:54"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Postponement Of Credit Of Right Issue And Listing Of Shares",
            "news_body": "Postponement of credit of right issue and listing of shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91181ec6-763d-497f-ac60-5ee9f554b73d.pdf",
            "news_date": "2025-08-25 21:45:51"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of board meeting for allotment of right issue shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a69d60d5-9efa-4a8d-ace8-fda5034a65cc.pdf",
            "news_date": "2025-08-25 21:27:42"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Postponement In Finalization Of Basis Of Allotment And Allotment Schedule For Rights Issue",
            "news_body": "We wish to inform you that the finalisation of basis of allotment and allotment is currently under process in consultation with the NSE. and RTA and has been postponed and now will be carried out on August 25 2025\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9e2ae79-5058-4b3c-a724-a525f0f9f958.pdf",
            "news_date": "2025-08-22 20:28:18"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended 30Th June 2025",
            "news_body": "Financial Results for quarter ended 30th June 2025 approved by Board of Directors at their meeting held on 13th August 2025",
            "news_id": "6c8bce30-90b8-4d9c-bb87-7606fbc75bc7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61b3ebf8-616e-4a73-a1e8-31fc33323139.pdf",
            "news_date": "2025-08-13 19:05:42",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For Quarter Ended 30Th June 2025",
            "news_body": "Financial Results for quarter ended 30th June 2025 approved by Board of Directors at their meeting held on 13th August 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61b3ebf8-616e-4a73-a1e8-31fc33323139.pdf",
            "news_date": "2025-08-13 19:05:42"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board meeting is enclosed herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c71699e-0932-45aa-9a90-a768c827d307.pdf",
            "news_date": "2025-08-13 18:53:31"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results",
            "news_body": "Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f386d88-d62a-4617-83a8-7ba47787a2bb.pdf",
            "news_date": "2025-08-07 11:35:37"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement regarding proposed right issue of the fully paid equity shares of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd1c8381-e9ac-428c-bfe2-22324676220a.pdf",
            "news_date": "2025-07-18 14:55:38"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We hereby submit Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation 2018 received from MUFG Intime India Private Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a287a1d1-3bd5-4ccb-8f43-ab5c82852932.pdf",
            "news_date": "2025-07-15 17:56:45"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Bonds / Right issue",
            "caption": "Corporate Action-Outcome of Right issue",
            "news_body": "Submission of Letter of Offer in connection with Proposed Right Issue of the Fully Paid - up Equity shares of Kilitch Drugs (India) Limited in terms of Regulation 71(2) of the SEBI (Issue of Capital and Disclosure Requirements) Regulation 2018.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c2ee08a-0231-4e23-b5ac-a5e6c9e7e510.pdf",
            "news_date": "2025-07-12 17:32:56"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Corrigendum To Outcome Of Board Meeting Held On July 12 2025",
            "news_body": "Submission of Corrigendum of Outcome of Board meeting held on July 12 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c484935d-ec93-4fbf-b80b-84deb85cfe0f.pdf",
            "news_date": "2025-07-12 14:16:36"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Scheduled To Approve Issue Period And Letter Of Offer",
            "news_body": "Board meeting to approve issue period and letter of offer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c153f55-7ce7-4dae-9733-3bab29f3d924.pdf",
            "news_date": "2025-07-12 10:39:58"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date",
            "news_body": "Intimation of Record for the purpose of right issue",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98ad895a-6dfc-4be6-9861-6fffada79eaf.pdf",
            "news_date": "2025-07-09 19:16:05"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Issue of equity shares of company on right issue basis",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=961bb94f-8e03-4e8c-b354-d8c2ff4a6924.pdf",
            "news_date": "2025-07-09 19:12:19"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Raising of Fund by way of issue of equity shares of the company on right issue basis",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5e0f03d-eb67-4ffe-80e6-0eb194cb13b0.pdf",
            "news_date": "2025-07-02 12:57:32"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of trading window closure for declaration of financial results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bc04b47-40f2-4776-ad8e-50d385684d61.pdf",
            "news_date": "2025-06-29 14:38:13"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approval Of The Proposal For Fund Raising By Way Of Issue Of Equity Shares Through Right Issue And Any Other Businesses",
            "news_body": "Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/07/2025 inter alia to consider and approve for fund raising by way of issue of equity shares through right issue through right issue",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbcecee1-52ef-4773-90a5-09dd51cf4bea.pdf",
            "news_date": "2025-06-29 14:30:14"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "We are enclosing herewith the press release relating to Financial Results for Q4FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a13965e-ceed-4663-9b4a-0102081f0b12.pdf",
            "news_date": "2025-05-22 17:14:07"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "We are submitting the annual secretarial compliance report for the year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59de3c00-ed12-4d47-8297-219d7db50a60.pdf",
            "news_date": "2025-05-21 17:29:29"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Extract of Financial Results for the quarter and year ending 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=045d12a6-c414-4c87-998b-b2379a46666a.pdf",
            "news_date": "2025-05-21 15:56:21"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Approved and Considered audited standalone and consolidated financial results for the quarter ended 31st March 2025",
            "news_id": "e4ed27b5-8b2f-44c4-8d5d-54abd0dfbdf1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a426f9dd-1a32-4164-9f7b-0594baf153c6.pdf",
            "news_date": "2025-05-19 21:31:45",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Approved and Considered audited standalone and consolidated financial results for the quarter ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a426f9dd-1a32-4164-9f7b-0594baf153c6.pdf",
            "news_date": "2025-05-19 21:31:45"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=390394d1-fb9d-4da4-9afd-76a37f5adf95.pdf",
            "news_date": "2025-05-19 21:21:04"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving Standalone And Consolidated Quarterly Financial Results For The Period Ended 31St March 2025",
            "news_body": "Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47e7805b-337f-461c-9e56-e376db53f331.pdf",
            "news_date": "2025-05-13 14:47:09"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We are attaching herewith the certificate received from MUFG Intime India Private Limited the RTA of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d42ce24-6b95-46da-a02e-ebbe9caac68f.pdf",
            "news_date": "2025-04-15 11:53:28"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Reply To Query LODR Regarding Completion Of Tenure Of Independent Director",
            "news_body": "We herewith attached our reply",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37500971-91bf-4537-8d13-e3c1a5bff1e0.pdf",
            "news_date": "2025-04-09 14:47:15"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Retirement",
            "caption": "Announcement under Regulation 30 (LODR)-Retirement",
            "news_body": "We hereby inform you that Mr. Hemang Jagadish Engineer has completed his secon term as Independent Director of the Company on 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07026201-12b6-41d2-a83a-ea32608b9c16.pdf",
            "news_date": "2025-04-07 12:25:19"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Trading Window for dealing in securities of the Company will remain closed for all the Designated Persons of the Company with effect from Tuesday 1st April 2025 till expiry of 48 hours after declaration of Financial Results of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93e3fa31-6154-481b-baa8-38d53e8b63d2.pdf",
            "news_date": "2025-03-26 16:38:09"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby inform the exchange regarding newspaper publication of the extract of the financial result for the quarter ending 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f40e3015-5ca5-41b6-b4ed-f1803d553d83.pdf",
            "news_date": "2025-02-14 14:29:29"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Enclosed herewith the press release relating to 3FY25 financial results of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7aa65bc1-64d2-4557-931b-e4898ac056a7.pdf",
            "news_date": "2025-02-12 15:00:15"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "We are submitting herewith the integrated filing (financials) for the quarter ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31af75b5-fbb7-4f69-b41e-2d97f0858651.pdf",
            "news_date": "2025-02-11 19:04:55"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Considered And Approved Unaudited Financial Result For December 31 2024",
            "news_body": "Considered and Approved unaudited financial results for quarter ending 31st December 2024",
            "news_id": "ab857a86-015d-4e9a-a933-68e7bf708e69",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1088269c-4fa2-4401-a77e-c344e14c6aa8.pdf",
            "news_date": "2025-02-11 18:23:24",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Considered And Approved Unaudited Financial Result For December 31 2024",
            "news_body": "Considered and Approved unaudited financial results for quarter ending 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1088269c-4fa2-4401-a77e-c344e14c6aa8.pdf",
            "news_date": "2025-02-11 18:23:24"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Mr. Bhavin Mukund Mehta Wholetime Director appointed as Vice Chairman of PHARMEXCIL",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a07fdfd8-8d0e-454f-812f-1640cfefaf14.pdf",
            "news_date": "2025-02-04 09:41:19"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ending 31St December 2024",
            "news_body": "KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=960cbccb-b0fb-4792-abba-00bb8a503348.pdf",
            "news_date": "2025-02-03 17:40:10"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015",
            "news_body": "Pursuant to provisions of regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby would like to inform you that the Company has made additional investment of USD 200000 to acquire equity shares of Kilitch Estro Biotech PLC Foreign subsidiary of the Company to meet working capital requirement of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a168d040-713a-4b32-a043-b0900a0062a0.pdf",
            "news_date": "2025-01-21 17:34:22"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "we are submitting herewith the certificate received from Link Intime India Private Limited the registrar and share transfer agent of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63323d7b-d69e-4a42-b033-9323e11a7399.pdf",
            "news_date": "2025-01-14 13:25:51"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "We hereby inform you that the Company has received intimation from the registrar and share transfer agent to issue duplicate share certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dac46244-2762-4589-b287-3612e1cd8379.pdf",
            "news_date": "2024-12-09 16:48:49"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of copy of Newspaper publication of extract of financial results for the quarter ended 30th September, 2024 to stock exchanges",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=234df482-3275-49ea-8980-247e470873e9.pdf",
            "news_date": "2024-11-14 18:28:25"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Submission Of Outcome Of Board Meeting",
            "news_body": "Submitting herewith the outcome of board meeting for approval of unaudited financial results for the quarter ended 30.09.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c65e3dc8-395d-42a3-b4a2-6db8ad2b28b6.pdf",
            "news_date": "2024-11-12 18:36:58"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th September, 2024",
            "news_body": "We are submitting herewith the financial results for the quarter ended 30th September, 2024",
            "news_id": "9abe0173-0069-4f5a-8ca8-4ee2df6d6126",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e78b54a-c619-4173-aa47-ee502c84c1a1.pdf",
            "news_date": "2024-11-12 18:32:39",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th September, 2024",
            "news_body": "We are submitting herewith the financial results for the quarter ended 30th September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e78b54a-c619-4173-aa47-ee502c84c1a1.pdf",
            "news_date": "2024-11-12 18:32:39"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Pursuant to Regulation 39(3) of SEBI LODR Regulations, 2015, we hereby intimate the issue of Duplicate share certificate to one of the shareholders due to loss of share certificate by him",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c17bc761-0f9b-409f-84be-070dd75ea995.pdf",
            "news_date": "2024-11-11 17:15:38"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For Quarter Ended September, 2024",
            "news_body": "KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab047c67-4200-443d-8779-83c0abd982b8.pdf",
            "news_date": "2024-11-04 18:00:47"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation Of Loss of share certificate by Mr. Ved Bhushan received from Company to stock exchanges",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a017af5d-78fd-4aef-abcd-cf763dbe38b1.pdf",
            "news_date": "2024-10-22 11:24:10"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation of Issue of Duplicate Share Certificate under regulation 39(3) of the listing regulation to the stock exchange",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64f25a14-0413-40ab-a8e5-3c31fd9981b3.pdf",
            "news_date": "2024-10-19 17:31:44"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "We are submitting herewith the copy of certificate received from Registrar and Share Transfer Agent of the Company under Regulation 74(5) of SEBI (DP) Regulation, 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=491bd27c-cb9b-411f-bed7-20413053c2fa.pdf",
            "news_date": "2024-10-09 15:31:11"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Issue of Duplicate Share Certificate to Mr. Vishwa Jit Sharma due to loss of original share certificate by him",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8747ea2-bd8e-4367-b703-eaa07be2f8a8.pdf",
            "news_date": "2024-10-07 13:51:52"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
            "news_body": "We hereby submit Scrutinizer Report for the 32ND AGM of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ab8968c-9165-46cb-abb9-9a9bf97b0ee8.pdf",
            "news_date": "2024-09-27 23:02:16"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "We hereby submit proceeding and outcome of 32nd Annual General meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d0f425e-4796-44e5-843e-05c415d78cef.pdf",
            "news_date": "2024-09-27 16:45:55"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "We hereby inform you that the trading window for dealing in securities of the Company will remain closed for designated persons of the Company commencing from 1st October, 2024 till expiry of 48 hours after the declaration of unaudited Financial Results of the Company for the quarter ended 30th September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a6aeaa0-182b-45a2-a4d2-fec0e6a91800.pdf",
            "news_date": "2024-09-25 15:36:46"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation of Issue of Duplicate Share Certificates to shareholders to Stock Exchange under regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3400517-940d-4434-956d-1f8d209b4958.pdf",
            "news_date": "2024-09-21 14:40:45"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Intimation To Stock Exchange Regarding Report Submitted By Acquirer To The SEBI Under Regulation 10(7) Of SEBI SAST Regulation",
            "news_body": "intimation to stock exchange regarding report submitted by acquirer to the SEBI under regulation 10(7) of SEBI SAST regulation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fe77df4-c016-44e5-8f27-4f6abb8541d9.pdf",
            "news_date": "2024-09-13 14:20:27"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We are submitting herewith the copy of extract of Notice of 32nd AGM published in the newspaper",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1100a0e9-5ff9-4d7f-ac02-dfdb6ed2cca7.pdf",
            "news_date": "2024-09-03 17:45:43"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Corp. Action",
            "descriptor": "Book Closure",
            "caption": "Intimation Of Book Closure",
            "news_body": "We hereby inform you that the Register of Members and Register of Share Transfer shall remain closed from Friday, 20th September, 2024 till Friday, 27th September, 2024 for the purpose of AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e16dc253-be09-4149-bb94-297bc911125c.pdf",
            "news_date": "2024-09-02 14:01:55"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Notice Of 32Nd Annual General Meeting",
            "news_body": "We are hereby submitting the Notice of 32nd Annual General Meeting of the Company to be held on 27th September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65cc2a2d-6ccf-4c7a-b653-e30d3a4793d3.pdf",
            "news_date": "2024-09-02 13:40:41"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Pursuant to Regulations 34 of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations 2015 we are submitting herewith the Annual Report for the Financial Year 2023-24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34487483-10a2-4f29-9942-2db894de7334.pdf",
            "news_date": "2024-09-02 13:31:20"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Appointment of Statutory Auditor/s",
            "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulation, this is to inform you that the Board of Directors at their meeting held today appointed M/s Sharat & Associates, Chartered Accountant as Statutory Auditors of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1371a2f7-52c7-4801-b5ec-e164a23fbe95.pdf",
            "news_date": "2024-08-30 17:03:50"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations, this is to inform you that the Board of Directors approved the appointment of M/s C Sharat & Company, Chartered Accountants as a Statutory Auditors of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e592ac73-799d-4611-b063-aa3b3c8393e6.pdf",
            "news_date": "2024-08-30 16:47:26"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mira Mehta",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5BACDC91_2E26_4069_A2DD_9A22EA88277F_102439.pdf",
            "news_date": "2024-08-30 10:24:42"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mira Bhavin Mehta",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04BF1B40_84EF_4447_89C0_21A001FC1271_175605.pdf",
            "news_date": "2024-08-27 17:56:08"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mira Bhavin Mehta",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7085C1D0_BB45_40C0_8445_A261E0716305_144935.pdf",
            "news_date": "2024-08-27 14:49:38"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Appointment of Statutory Auditor/s",
            "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s",
            "news_body": "Appointment of M/s. AVHP & Company LLP, Chartered Accountant (FRN:W100671) as Statutory Auditors of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05c42e9d-895d-4445-b1fc-808859b72eb0.pdf",
            "news_date": "2024-08-26 17:01:34"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Issue of Duplicate Share certificate to S Mallikarjunappa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4205881d-042b-4f0f-b1a0-d9ab61cc02de.pdf",
            "news_date": "2024-08-20 10:45:28"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Resignation of Statutory Auditors",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors",
            "news_body": "we hereby inform you that Suryaprakash Maurya  co. Chartered Accountants, statutory auditors of the Company have tendered their resignation vide letter dated 13th August, 2024 informing their inability to continue as statutory auditor of the company with immediate effect.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17da2285-7097-4bfc-9286-e4bb9820d96c.pdf",
            "news_date": "2024-08-13 18:47:40"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011",
            "caption": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mira Bhavin Mehta",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C2CC333F_1926_4A33_8846_B222180B0986_165741.pdf",
            "news_date": "2024-08-13 16:57:59"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of Newspaper Publication of extract of financial results for the quarter ended 30th June, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b79def8-f436-425d-a0e1-ee926b263823.pdf",
            "news_date": "2024-08-10 12:40:34"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Submission Of Quarterly Standalone And Financial Results For The Quarter Ended 30Th June 2024",
            "news_body": "Submission of Quarterly Standalone and Financial Results for the quarter ended 30th June 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86c7da71-e840-423e-b4b5-990b63f9598f.pdf",
            "news_date": "2024-08-08 18:28:43"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Financial Results For The Quarter Ended 30Th June, 2024",
            "news_body": "Submission of Standalone and Consolidated Results for the quarter ended 30th June, 2024",
            "news_id": "cdf51bf1-6ce8-4e25-94f4-c41ccee0efaf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26395e63-0278-48e0-b172-24320a46e7cd.pdf",
            "news_date": "2024-08-08 18:24:57",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Submission Of Financial Results For The Quarter Ended 30Th June, 2024",
            "news_body": "Submission of Standalone and Consolidated Results for the quarter ended 30th June, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26395e63-0278-48e0-b172-24320a46e7cd.pdf",
            "news_date": "2024-08-08 18:24:57"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approval Of Unaudited Financial Results For The Period Ended 30Th June 2024",
            "news_body": "KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 ,inter alia, to consider and approve unaudited financial results for the period ended 30th June 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c49ed2b3-6245-4f17-b791-299e2f2c3f61.pdf",
            "news_date": "2024-08-01 16:45:11"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation of Issue of Duplicate share certificate to Shesappa Suvarna",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55cd3340-1386-4d7f-95bc-927c95af73d5.pdf",
            "news_date": "2024-07-29 14:34:29"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Submission of Certificate under regulation 74(5) of SEBI (DP) Regulations.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c6e5f8c-0627-4a96-8b68-ba0907937279.pdf",
            "news_date": "2024-07-06 17:31:00"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation regarding loss of share certificate by the shareholders",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8da3cd86-1bff-458d-9f6b-4b2f80fd61ad.pdf",
            "news_date": "2024-06-28 17:16:59"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation of issue of duplicate share certificate to the shareholders detailed in the attached file",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0297a7d0-fd34-4ca2-8257-b26e292e7ec0.pdf",
            "news_date": "2024-06-28 17:07:28"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading window with effect from 1st July, 2024 upto 48 hours from the declaration of unaudited results for the quarter and year ended 30th June, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb9dcb77-1dd4-4622-bef5-d295be4230e2.pdf",
            "news_date": "2024-06-28 16:56:47"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Submission of Transcript of Earning Call",
            "news_id": "5a6e64f6-f1a0-41a7-8d56-2ff0e2c2ee43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c02771e-7374-416f-967b-7a5f0d228187.pdf",
            "news_date": "2024-06-14 12:04:17",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Submission of Transcript of Earning Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c02771e-7374-416f-967b-7a5f0d228187.pdf",
            "news_date": "2024-06-14 12:04:17"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of earning call",
            "news_id": "d7ee7bd9-1442-41b0-92ec-f8ca68c88f22",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b4a6b60-31fb-4b19-80e1-5377ea32439a.pdf",
            "news_date": "2024-06-10 14:16:35",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of earning call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b4a6b60-31fb-4b19-80e1-5377ea32439a.pdf",
            "news_date": "2024-06-10 14:16:35"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "we hereby inform you that the Company will be hosting an investor and analyst conference call on Monday, 10th June, 2024 at 11:00 am to discuss the performance for the quarter and financial year ended 31st March, 2024 as per the invite enclosed herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eab158c0-9e0b-42d0-9a64-c9636791ada1.pdf",
            "news_date": "2024-06-05 18:41:55"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation to the stock exchange regarding receipt of intimation of loss of share certificate by one of the shareholers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7fedf84-98b5-40f8-b828-a0b9de557856.pdf",
            "news_date": "2024-06-05 16:32:53"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Quarterly Financial Results For The Year Ended 31St March 2024",
            "news_body": "Quarterly financial results for the year ended 31st March, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ff8bcf6-96f3-41f3-8ac5-ec62081c6622.pdf",
            "news_date": "2024-05-27 19:28:57"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Year Ended 31St March 2024",
            "news_body": "Financial Results for the year ended 31st March, 2024",
            "news_id": "03dc4af9-f6b6-4bcc-87f6-0e77de2b55b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=556c1823-56e6-4ace-8af4-fa98f8cfd6ee.pdf",
            "news_date": "2024-05-27 19:21:47",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Year Ended 31St March 2024",
            "news_body": "Financial Results for the year ended 31st March, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=556c1823-56e6-4ace-8af4-fa98f8cfd6ee.pdf",
            "news_date": "2024-05-27 19:21:47"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31St March, 2024",
            "news_body": "KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve financial results for the quarter and year ended 31st March, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04874a2d-bcb7-4b73-9282-a383e5dfcf56.pdf",
            "news_date": "2024-05-20 11:13:51"
        },
        {
            "co_code": 3630,
            "bse_code": 524500,
            "isin": "INE729D01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "We hereby inform that the company has received intimation regarding loss of share certificate by Narayan Shet N Verekar",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a651852c-2cd1-4897-8a6d-d13eaea8aa18.pdf",
            "news_date": "2024-05-18 11:45:18"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For The Quarter Ended 31St December, 2023",
            "news_body": "Submission of financial results for the quarter ended 31st December, 2023",
            "news_id": "d4415d6a-605e-44cc-a73b-3647e241be2e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56ac2179-e4fb-49c6-9b4e-ab2b92f7f0a1.pdf",
            "news_date": "2024-02-08 18:06:14",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December, 2023",
            "news_body": "Declaration of Financial Results for the quarter ended 31st December, 2023",
            "news_id": "acc6f77b-7e78-4b9c-b1a3-64cb68abd050",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cda068d-fec8-498e-b33d-a67e4ed73353.pdf",
            "news_date": "2024-02-08 18:00:00",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th September, 2023",
            "news_body": "Enclosed please find Financial Results for the quarter ended 30th September, 2023",
            "news_id": "9680b137-48e7-46a0-9869-bec04ad7e8b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fe11231-7c4a-4d96-9338-ab34764d2c1a.pdf",
            "news_date": "2023-11-09 18:45:56",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Considered And Approved Unaudited Financials Results For The Quarter Ended 30Th June, 2023",
            "news_body": "Considered and approved financial results for the quarter ended 30th June, 2023",
            "news_id": "a8fa2880-91c9-463f-8c19-d98a80e39a22",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6bd4fde-7e4d-4ff8-8820-3ba7712486b7.pdf",
            "news_date": "2023-08-11 13:55:40",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Recording Of Conference Call",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, further to our intimation dated 29th May, 2023 regarding earnings call, the audio recording of the call held today i.e. Friday, 2nd June, 2023 is available on our website. The same can be accessed through below link:https://kilitch.com/wp-content/uploads/2023/06/Kilitch-Drugs-India-Limited-Q4-FY23-Concall-Audio.mp3",
            "news_id": "87422cf1-1a67-4944-98b1-15417b8715da",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69db9cbe-f57a-4e31-a5dc-528ac3f3536c.pdf",
            "news_date": "2023-06-02 17:13:22",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended 31St March, 2023",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,we hereby would like to inform you that Board of Directors of the Company, at its meeting held today i.e. 29th May, 2023 have considered and approved the following; 1. Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2023. The copy of Audited Financial Results (Standalone and Consolidated) as adopted and approved by the Board of Directors and Auditor''s report thereon are attached herewith for your ready reference.2. Pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that the Statutory Auditors of the Company have issued their audit reports with unmodified (i.e., unqualified) opinion on the Financial Statements (Standalone and Consolidated) for the year ended on 31st March, 2023.",
            "news_id": "ce8ba6cf-fa16-41f2-93ef-f7971c8383f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a40e34c5-df65-449c-abeb-3f6c6f91c15f.pdf",
            "news_date": "2023-05-29 18:09:56",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December, 2022",
            "news_body": "Financial Results for the quarter ended 31st December, 2022",
            "news_id": "5a67b66b-06c1-478e-8423-c72d08084a28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=735c0c49-ec6e-46a6-8cae-5f2924d8aeaf.pdf",
            "news_date": "2023-02-14 18:02:39",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2022, Pursuant To Regulation 23(9) Of Tile SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In accordance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure of Related Party Transactions of the Company for the half-year ended 30th September, 2022.",
            "news_id": "6912f7ad-beac-407f-805c-7fd528314446",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67b8e1a0-a7af-46ff-aec1-ad0a1e3a1ca4.pdf",
            "news_date": "2022-11-28 16:23:08",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th September, 2022",
            "news_body": "In continuation of our letter dated 3rd November, 2022 and pursuant to Regulation 30 and Regulation 33 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, 14th November, 2022 have considered and approved the following;<BR> <BR> 1. Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th September, 2022. The copy of Unaudited Financial Results (Standalone and Consolidated) as considered and approved by the Board of Directors along with Limited Review Report by the Auditors are enclosed herewith for your ready reference.<BR>",
            "news_id": "5614c67e-79d9-4b7c-8c8b-d5abfd3ec533",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cb5bc07-a87a-4d53-8a13-2e6b05554372.pdf",
            "news_date": "2022-11-14 19:10:14",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Consideration And Approval Of Financial Results",
            "news_body": "Board of Directors approved unaudited financial results for the quarter ended 30th June, 2022. approved the appointment of Cost Auditor. Approved Notice of 30th Annual General Meeting of the Company and fixed the date of the same.",
            "news_id": "3ebc60f2-32f3-4828-a24e-18f9676d4f7f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05e802c4-2179-4bdb-afd4-17b5407304ce.pdf",
            "news_date": "2022-08-10 18:31:09",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2022, Pursuant To Regulation 23(9) Of Tile SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In accordance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure of Related Party Transactions of the Company for the half-year ended 31st March, 2022",
            "news_id": "2a4d63a6-5223-42af-a96d-3c87091674a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75695ab9-21a9-4bdb-83e3-c700af9948f8.pdf",
            "news_date": "2022-06-08 16:14:36",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended 31.03.2022",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,we hereby would like to inform you that Board of Directors of the Company, at its meeting held today i.e.26th May, 2022, have considered and approved the following; <BR> <BR> 1.Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2022. The copy of Audited Financial Results (Standalone and Consolidated) as adopted and approved by the Board of Directors and Auditor''s report thereon are attached herewith for your ready reference.<BR> <BR> 2.Pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that the Statutory Auditors of the Company have issued their audit reports with unmodified (i.e., unqualified) opinion on the Financial Statements (Standalone and Consolidated) for the year ended on 31st March, 2022.<BR> <BR> <BR>",
            "news_id": "2c1ca8c3-21b3-4b29-a451-883f357567eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7397b4e-5e95-47ac-b001-efba55a526f0.pdf",
            "news_date": "2022-05-26 18:16:29",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of The Un-Audited Financial Results Of The Company For The Quarter Ended 31St December 2021;",
            "news_body": "In continuation to our letter dated 7th February 2022, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 14th February, 2022, have -<BR> <BR> 1.Considered and approved the Un-audited financial results of the company for the quarter ended 31st December 2021;<BR> <BR> In this connection please find enclosed the copy of Un-audited Standalone & Consolidated financial Results of the Company for the quarter ended 31st December 2022 along with Limited Review Report by the Statutory Auditors of the Company as 'Annexure-I'.  <BR> <BR> The meeting commenced at 04: 00 P.M. and concluded at 07:00 P.M.<BR> <BR> The above is for information and dissemination to the public at large.",
            "news_id": "7c394f06-80ff-4441-bee9-00c78ad6f695",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fac39b65-89f3-4e4b-a314-19ba0d7c8576.pdf",
            "news_date": "2022-02-14 19:05:23",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Approval Of The Un-Audited Financial Results Of The Company For The Quarter Ended 31St December 2021;",
            "news_body": "In continuation to our letter dated 7th February 2022, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 14th February, 2022, have -<BR> <BR> 1.Considered and approved the Un-audited financial results of the company for the quarter ended 31st December 2021;<BR> <BR> In this connection please find enclosed the copy of Un-audited Standalone & Consolidated financial Results of the Company for the quarter ended 31st December 2022 along with Limited Review Report by the Statutory Auditors of the Company as 'Annexure-I'.  <BR> The meeting commenced at 04: 00 P.M. and concluded at 07:00 P.M.<BR> <BR> The above is for information and dissemination to the public at large.<BR>",
            "news_id": "7c719ab8-2f8c-49fa-9171-6d1fc4ddf12d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b66a6915-9e92-49c7-807b-d134ebf744cc.pdf",
            "news_date": "2022-02-14 19:00:26",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transaction on consolidated basis for the half year ended 30th  September, 2021, in the format specified on the relevant accounting standards.",
            "news_id": "33ff1a2b-b938-4658-9b2d-4b1c38ff42a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c14cbeca-3f3e-4034-ac76-7afe638755d0.pdf",
            "news_date": "2021-11-30 14:37:27",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 12Th November, 2021",
            "news_body": "In continuation to our letter dated 2nd November 2021, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 12th November, 2021, have considered and approved the following-<BR> <BR> 1.The Un-audited financial results of the company for the quarter and half year ended 30th September 2021;",
            "news_id": "81ce382f-dbbc-4983-a344-3322a048e2a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6149cf93-ada7-49ad-81d9-d6be3de58182.pdf",
            "news_date": "2021-11-12 19:48:37",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 12Th November, 2021",
            "news_body": "In continuation to our letter dated 2nd November 2021, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 12th November, 2021, have considered and approved the following-<BR> <BR> 1.The Un-audited financial results of the company for the quarter and half year ended 30th September 2021;",
            "news_id": "46708a19-b171-4750-b176-ad12af26524b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8d77788-a4b4-450d-8b56-cb95bd9560f4.pdf",
            "news_date": "2021-11-12 19:48:04",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November, 2021",
            "news_body": "In continuation to our letter dated 2nd November 2021, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 12th November, 2021, have considered and approved the following-<BR> <BR> 1.The Un-audited financial results of the company for the quarter and half year ended 30th September 2021;<BR>",
            "news_id": "57d3343b-3c07-431a-aed8-b0ce7a23d92d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86d4d732-3757-4f26-82dc-c76acca856af.pdf",
            "news_date": "2021-11-12 19:42:53",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 13Th August 2021",
            "news_body": "In continuation to our letter dated 5th August 2021, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 13th August 2021, have considered and approved the following-<BR> <BR> 1.The Un-audited financial results of the company for the quarter ended 30th June 2021;<BR> <BR> In this connection please find enclosed the copy of Un-audited Standalone financial Results of the Company for the quarter ended 30th June 2021 along with Limited Review Report by the Statutory Auditors of the Company as 'Annexure-I'.  <BR> <BR> 2.The appointment of M/s Suryaprakash Maurya & Co (FRN: 147410W) as the Statutory Auditor of the Company to hold office from the conclusion of 29th AGM till the conclusion of 34th AGM.",
            "news_id": "9ac0dbf5-3636-428c-89e8-1dd194455982",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cc7c8f7-e1d3-49c3-a9e3-1ac8fc78bf74.pdf",
            "news_date": "2021-08-13 17:09:34",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transaction on consolidated basis for the half year ended 31st March 2021, in the format specified on the relevant accounting standards.",
            "news_id": "bc893443-d710-49e6-92fa-82bb1bb0a041",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39a9a59c-1d2d-492c-9901-1097974cc71d.pdf",
            "news_date": "2021-07-08 16:28:46",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Financial Results For The Quarter And Year Ended 31St March, 2021",
            "news_body": "We enclosed herewith the audited standalone and consolidated financial results of the Company for the quarter and year ended 31st March, 2021, which have been approved and taken on record at the meeting of the Board of Directors of the Company held today, i.e. 22nd June, 2021.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we would like to confirm that M/s. A.M. Ghelani & Co., Chartered Accountants (Firm Registration no. 103173W)), Statutory Auditors of the Company, have issued Audit Reports with unmodified opinion on the above financial results.<BR> <BR> The meeting of Board of Directors held today commenced at 4:00 PM and concluded at 5:35 PM.",
            "news_id": "f3b364f8-3089-4bcb-9efe-586f0f1c88dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c435cbdf-68ea-44f0-b12f-f570c62b5b2b.pdf",
            "news_date": "2021-06-22 18:07:01",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}